β4 integrin-dependent formation of polarized three-dimensional architecture confers resistance to apoptosis in normal and malignant mammary epithelium

Cancer Cell

Volumn 2, Issue 3, 2002, Pages 205-216

  Weaver, Valerie M ^a   Lelièvre, Sophie ^b   Lakins, Johnathon N ^a   Chrenek, Micah A ^c   Jones, Jonathan C R ^d   Giancotti, Filippo ^e   Werb, Zena ^f   Bissell, Mina J ^g  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b PURDUE UNIVERSITY   (United States)

^c UNIVERSITY OF ALBERTA   (Canada)

^d NORTHWESTERN UNIVERSITY   (United States)

^e MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g LAWRENCE BERKELEY NATIONAL LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA4 INTEGRIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN;

APOPTOSIS; ARTICLE; BASEMENT MEMBRANE; BREAST CARCINOMA; BREAST CELL; CANCER GROWTH; CANCER RESISTANCE; CELL PROTECTION; CELL ULTRASTRUCTURE; CONTROLLED STUDY; GROWTH RATE; HEMIDESMOSOME; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN STRUCTURE; PROTEIN SYNTHESIS REGULATION; THREE DIMENSIONAL IMAGING; BREAST TUMOR; CELL CULTURE; CELL POLARITY; CYTOLOGY; EPITHELIUM CELL; EXTRACELLULAR MATRIX; FEMALE; GENE EXPRESSION REGULATION; METABOLISM; PATHOLOGY; PHYSIOLOGY; ULTRASTRUCTURE;

APOPTOSIS; BASEMENT MEMBRANE; BREAST NEOPLASMS; CELL POLARITY; EPITHELIAL CELLS; EXTRACELLULAR MATRIX; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INTEGRIN BETA4; NF-KAPPA B; TUMOR CELLS, CULTURED;

EID: 0036726312     PISSN: 15356108     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1535-6108(02)00125-3     Document Type: Article

References (69)

1. Adams, J.M., and Cory, S. (1998). The Bcl-2 protein family: arbiters of cell survival. Science 281, 1322-1326.
2. Baeuerle, P.A., and Baltimore, D. (1996). NF-κB: ten years after. Cell 87, 13-20.
3. Baldwin, A.S. (2001). Control of oncogenesis and cancer therapy resistance by the transcription factor NF-kappaB. J. Clin. Invest. 107, 241-246.
4. Bissell, M.J., and Radisky, D. (2001). Putting tumours in context. Nat. Rev. Cancer 1, 46-54.
5. Bissell, M.J., Weaver, V.M., Lelievre, S.A., Wang, F., Petersen, O.W., and Schmeichel, K.L. (1999). Tissue structure, nuclear organization, and gene expression in normal and malignant breast. Cancer Res. 59 Suppl. 7, 1757-1763a.
6. Borradori, L., and Sonnenberg, A. (1999). Structure and function of hemidesmosomes: more than simple adhesion complexes. J. Invest. Dermatol. 112, 411-418.
7. Boudreau, N., Sympson, C.J., Werb, Z., and Bissell, M.J. (1995). Suppression of ICE and apoptosis in mammary epithelial cells by extracellular matrix. Science 267, 891-893.
8. Briand, P., Nielsen, K.V., Madsen, M.W., and Petersen, O.W. (1996). Trisomy 7p and malignant transformation of human breast epithelial cells following epidermal growth factor withdrawal. Cancer Res. 56, 2039-2044.
9. Clarkson, R.W., Heeley, J.L., Chapman, R., Aillet, F., Hay, R.T., Wyllie, A., and Watson, C.J. (2000). NF-kappaB inhibits apoptosis in murine mammary epithelia. J. Biol. Chem. 275, 12737-12742.
10. Costello, R.T., Gastaut, J.A., and Olive, D. (1999). Tumor escape from immune surveillance. Arch. Immunol. Ther. Exp. 47, 83-88.
11. Damiano, J.S., Cress, A.E., Hazlehurst, L.A., Shtil, A.A., and Dalton, W.S. (1999). Cell adhesion mediated drug resistance (CAM-DR): role of integrins and resistance to apoptosis in human myeloma cell lines. Blood 93, 1658-1667.
12. Davis, T.L., Cress, A.E., Dalkin, B.L., and Nagle, R.B. (2001). Unique expression pattern of the alpha6beta4 integrin and laminin-5 in human prostate carcinoma. Prostate 46, 240-248.
13. Day, M.L., Zhao, X., Vallorosi, C.J., Putzi, M., Powell, C.T., Lin, C., and Day, K.C. (1999). E-cadherin mediates aggregation-dependent survival of prostate and mammary epithelial cells through the retinoblastoma cell cycle control pathway. J. Biol. Chem. 274, 9656-9664.
14. Desoize, B., and Jardillier, J. (2000). Multicellular resistance: a paradigm for clinical resistance? Crit. Rev. Oncol. Hematol. 36, 193-207.
15. Dowling, J., Yu, Q.C., and Fuchs, E. (1996). Beta4 integrin is required for hemidesmosome formation, cell adhesion and cell survival. J. Cell Biol. 134, 559-572.
16. Durand, R.E., and Olive, P.L. (2001). Resistance of tumor cells to chemoand radiotherapy modulated by the three-dimensional architecture of solid tumors and spheroids. Methods Cell Biol. 64, 211-233.
17. Fiorini, E., Marchisio, P.C., Scupoli, M.T., Poffe, O., Tagliabue, E., Brentegani, M., Colombatti, M., Santini, F., Tridente, G., and Ramarli, D. (2000). Adhesion of immature and mature T cells induces in human thymic epithelial cells (TEC) activation of IL-6 gene transcription factors (NF-kappaB and NF-IL6) and IL-6 gene expression: role of alpha3/beta1 and alpha6beta4 integrins. Dev. Immunol. 7, 195-208.
18. Goldfinger, L.E., Hopkinson, S.B., deHart, G.W., Collawn, S., Couchman, J.R., and Jones, J.C. (1999). The alpha3 laminin subunit, alpha6beta4 and alpha3beta1 integrin coordinately regulate wound healing in cultured epithelial cells and in the skin. J. Cell Sci. 112, 2615-2629.
19. Graham, C.H., Kobayashi, H., Stankiewicz, K.S., Man, S., Kapitain, S.J., and Kerbel, R.S. (1994). Rapid acquisition of multicellular drug resistance after a single exposure of mammary tumor cells to antitumor alkylating agents. J. Natl. Cancer Inst. 86, 975-982.
20. Gudjonsson, T., Ronnov-Jessen, L., Villadsen, R., Rank, F., Bissell, M.J., and Petersen, O.W. (2002). Normal and tumor-derived myoepithelial cells differ in their ability to interact with luminal breast epithelial cells for polarity and basement membrane deposition. J. Cell Sci. 115, 39-50.
21. Hauptmann, S., Denkert, C., Lohrke, H., Tietze, L., Ott, S., Klosterhalfen, B., and Mittermayer, C. (1995). Integrin expression on colorectal tumor cells growing as monolayers, as multicellular tumor spheroids, or in nude mice. Int. J. Cancer 61, 819-825.
22. Howlett, A.R., Bailey, N., Damsky, C., Petersen, O.W., and Bissell, M.J. (1995). Cellular growth and survival are mediated by beta 1 integrins in normal human breast epithelium but not in breast carcinoma. J. Cell Sci. 108, 1945-1957.
23. Hurley, L.H. (2002). DNA and its associated processes as targets for cancer therapy. Nat. Rev. Cancer 2, 188-200.
24. Jones, J.L., Royall, J.E., Critchley, D.R., and Walker, R.A. (1997). Modulation of myoepithelial-associated alpha6beta4 integrin in a breast cancer cell line alters invasive potential. Exp. Cell Res. 235, 325-333.
25. Jones, J.C., Hopkinson, S.B., and Goldfinger, L.E. (1998). Structure and assembly of hemidesmosomes. Bioessays 20, 488-494.
26. Kaufmann, S.H., and Earnshaw, W.C. (2000). Induction of apoptosis by cancer chemotherapy. Exp. Cell Res. 256, 42-49.
27. Kerbel, R.S. (1994). Impact of multicellular resistance on the survival of solid tumors, including micrometastases. Invasion Metastasis 14, 50-60.
28. Kerbel, R.S., St Croix, B., Florenes, V.A., and Rak, J. (1996). Induction and reversal of cell adhesion-dependent multicellular drug resistance in solid breast tumors. Hum. Cell 9, 257-264.
29. Kim, D.W., Sovak, M.A., Zanieski, G., Nonet, G., Romieu-Mourez, R., Lau, A.W., Hafer, L.J., Yaswen, P., Stampfer, M., Rogers, A.E., et al. (2000). Activation of NF-kappaB/Rel occurs early during neoplastic transformation of mammary cells. Cacrinogenesis 21, 871-879.
30. Lelievre, S.A., Weaver, V.M., Nickerson, J.A., Larabell, C.A., Bhaumik, A., Petersen, O.W., and Bissell, M.J. (1998). Tissue phenotype depends on reciprocal interactions between the extracellular matrix and the structural organization of the nucleus. Proc. Natl. Acad. Sci. USA 95, 14711-14716.
31. Mainiero, F., Murgia, C., Wary, K.K., Curatola, A.M., Pepe, A., Blumemberg, M., Westwick, J.K., Der, C.J., and Giancotti, F.G. (1997). The coupling of alpha6beta4 integrin to Ras-MAP kinase pathways mediated by Shc controls keratinocyte proliferation. EMBO J. 16, 2365-2375.
32. Nakshatri, H., Bhat-Nakshatri, P., Martin, D.A., Goulet, R.J., Jr., and Sledge, G.W., Jr. (1997). Constitutive activation of NF-kappaB during progression of breast cancer to hormone-independent growth. Mol. Cell. Biol. 17, 3629-3639.
33. Narita, T., Kimura, N., Sato, M., Matsuura, N., and Kannagi, R. (1998). Altered expression of integrins in adriamycin-resistant human breast cancer cells. Anticancer Res. 18, 257-262.
34. Nicolson, G.L. (1988). Organ specificity of tumor metastasis: role of preferential adhesion, invasion and growth of malignant cells at specific secondary sites. Cancer Metastasis Rev. 7, 143-188.
35. Nista, A., Leonetti, C., Bernardini, G., Mattioni, M., and Santoni, A. (1997). Functional role of alpha4beta1 and alpha5beta1 integrin fibronectin receptors expressed on adriamycin-resistant MCF-7 human mammary carcinoma cells. Int. J. Cancer 72, 133-141.
36. Okumura, M., Uematsu, J., Hirako, Y., Nishizawa, Y., Shimizu, H., Kido, N., and Owaribe, K. (1999). Identification of the hemidesmosomal 500 kDa protein (HD-1) as plectin. J. Biochem. (Tokyo) 126, 1144-1150.
37. Petersen, O.W., Ronnov-Jessen, L., Howlett, A.R., and Bissell, M.J. (1992). Interaction with basement membrane serves to rapidly distinguish growth and differentiation pattern of normal and malignant human breast epithelial cells. Proc. Natl. Acad. Sci. USA 89, 9064-9068.
38. Pfohler, C., Fixemer, T., Jung, V., Dooley, S., Remberger, K., and Bonkhoff, H. (1998). In situ hybridization analysis of genes coding collagen IV alpha1 chain, laminin beta1 chain, and S-laminin in prostate tissue and prostate cancer: increased basement membrane gene expression in high-grade and metastatic lesions. Prostate 36, 143-150.
39. Pignatelli, M., and Stamp, G. (1995). Integrins in tumour development and spread. Cancer Surv. 24, 113-127.
40. Puduvalli, V.K. (2001). Brain metastases: biology and the role of the brain microenvironment. Curr. Oncol. Rep. 3, 467-475.
41. Putz, E., Witter, K., Offner, S., Stosiek, P., Zippelius, A., Johnson, J., Zahn, R., Riethmuller, G., and Pantel, K. (1999). Phenotypic characteristics of cell lines derived from disseminated cancer cells in bone marrow of patients with solid epithelial tumors: establishment of working models for human micrometastases. Cancer Res. 59, 241-248.
42. Rabinovitz, I., and Mercurio, A.M. (1996). The integrin alpha 6 beta 4 and the biology of carcinoma. Biochem. Cell Biol. 74, 811-821.
43. Rathmell, J.C., and Thompson, C.B. (2002). Pathways of apoptosis in lymphocyte development, homeostasis, and disease. Cell 109, S97-107.
44. Roninson, I.B., Broude, E.V., and Chang, B.D. (2001). If not apoptosis, then what? Treatment-induced senescence and mitotic catastrophe in tumor cells. Drug Resist. Updat. 4, 303-313.
45. Rousselle, P., Lunstrum, G.P., Keene, D.R., and Burgeson, R.E. (1991). Kalinin: an epithelium-specific basement membrane adhesion molecule that is a component of anchoring filaments. J. Cell Biol. 114, 567-576.
46. Ryan, M.C., Lee, K., Miyashita, Y., and Carter, W.G. (1999). Targeted disruption of the LAMA3 gene in mice reveals abnormalities in survival and late stage differentiation of epithelial cells. J. Cell Biol. 145, 1309-1323.
47. Santini, M.T., and Rainaldi, G. (1999). Three-dimensional spheroid model in tumor biology. Pathobiology 67, 148-157.
48. Scupoli, M.T., Fiorini, E., Marchisio, P.C., Poffe, O., Tagliabue, E., Brentegani, M., Tridente, G., and Ramarli, D. (2000). Lymphoid adhesion promotes human thymic epithelial cell survival via NF-(kappa) B activation. J. Cell Sci. 113, 169-177.
49. Seitz, C.S., Freiberg, R.A., Hinata, K., and Khavari, P.A. (2000). NF-kappaB determines localization and features of cell death in epidermis. J. Clin. Invest. 105, 253-260.
50. Sethi, T., Rintoul, R.C., Moore, S.M., MacKinnon, A.C., Salter, D., Choo, C., Chilvers, E.R., Dransfield, I., Donnelly, S.C., Strieter, R., and Haslett, C. (1999). Extracellular matrix proteins protect small cell lung cancer cells against apoptosis: a mechanism for small cell lung cancer growth and drug resistance in vivo. Nat. Med. 5, 662-668.
51. Singh, R.K., Tsan, R., and Radinsky, R. (1997). Influence of the host microenvironment on the clonal selection of human colon carcinoma cells during primary tumor growth and metastasis. Clin. Exp. Metastasis 15, 140-150.
52. Sovak, M.A., Bellas, R.E., Kim, D.W., Zanieski, G.J., Rogers, A.E., Traish, A.M., and Sonnenshein, G.E. (1997). Aberrant nuclear factor-kappaB/Rel expression and the pathogenesis of breast cancer. J. Clin. Invest. 100, 2952-2960.
53. Spinardi, L., Einheber, S., Cullen, T., Milner, T.A., and Giancotti, F.G. (1995). A recombinant tail-less integrin beta 4 subunit disrupts hemidesmosomes, but does not suppress alpha 6 beta 4-mediated cell adhesion to laminins. J. Cell Biol. 129, 473-487.
54. Stahl, S., Weitzman, S., and Jones, J.C. (1997). The role of laminin-5 and its receptors in mammary epithelial cell branching morphogenesis. J. Cell Sci. 110, 55-63.
55. St. Croix, B., Man, S., and Kerbel, R.S. (1998). Reversal of intrinsic and acquired forms of drug resistance by hyaluronidase treatment of solid tumors. Cancer Lett. 131, 35-44.
56. Streuli, C.H., Bailey, N., and Bissell, M.J. (1991). Control of mammary epithelial differentiation: basement membrane induces tissue-specific gene expression in the absence of cell-cell interaction and morphological polarity. J. Cell Biol. 115, 1383-1395.
57. Tagliabue, E., Ghirelli, C., Squicciarini, P., Aiello, P., Colnaghi, M.I., and Menard, S. (1998). Prognostic value of alpha 6 beta 4 integrin expression in breast carcinomas is affected by laminin production from tumor cells. Clin. Cancer Res. 4, 407-410.
58. Tanaka, K., Iwamoto, S., Gon, G., Nohara, T., Iwamoto, M., and Tanigawa, N. (2000). Expression of survivin and its relationship to loss of apoptosis in breast carcinomas. Clin. Cancer Res. 6, 127-134.
59. Tani, T., Lumme, A., Linnala, A., Kivilaakso, E., Kiviluoto, T., Burgeson, R.E., Kangas, L., Leivo, I., and Virtanen, I. (1997). Pancreatic carcinomas deposit laminin-5, preferably adhere to laminin-5, and migrate on the newly deposited basement membrane. Am. J. Pathol. 151, 1289-1302.
60. Taylor, S.T., Hickman, J.A., and Dive, C. (2000). Epigenetic determinants of resistance to etoposide regulation of Bcl- X(L) and Bax by tumor microenvironmental factors. J. Natl. Cancer Inst. 92, 18-23.
61. Taylor-Papadimitriou, J., D'Souza, B., Berdichevsky, F., Shearer, M., Martignone, S., and Alford, D. (1993). Human models for studying malignant progression in breast cancer. Eur. J. Cancer Prev. 2 (Suppl 3), 77-83.
62. Tergaonkar, V., Pando, M., Vafa, O., Wahl, G., and Verma, I. (2002). p53 stabilization is decreased upon NFkB activation: a role for NFkB in acquisition of resistance to chemotherapy. Cancer Cell 1, 493-503.
63. Thornberry, N.A., and Lazebnik, Y. (1998). Caspases: enemies within. Science 281, 1312-1316.
64. Van Riet, I., Vanderkerken, K., de Greet, C., and Van Camp, B. (1998). Homing behaviour of the malignant cell clone in multiple myeloma. Med. Oncol. 15, 154-164.
65. Wang, F., Weaver, V.M., Petersen, O.W., Larabell, C.A., Dedhar, S., Briand, P., Lupu, R., and Bissell, M.J. (1998). Reciprocal interactions between beta1-integrin and epidermal growth factor receptor in three-dimensional basement membrane breast cultures: a different perspective in epithelial biology. Proc. Natl. Acad. Sci. USA 95, 14821-14826.
66. Weaver, V.M., Fischer, A.H., Peterson, O.W., and Bissell, M.J. (1996). The importance of the microenvironment in breast cancer progression: recapitulation of mammary tumorigenesis using a unique human mammary epithelial cell model and a three-dimensional culture assay. Biochem. Cell Biol. 74, 833-851.
67. Weaver, V.M., Petersen, O.W., Wang, F., Larabell, C.A., Briand, P., Damsky, C., and Bissell, M.J. (1997). Reversion of the malignant phenotype of human breast cells in three-dimensional culture and in vivo by integrin blocking antibodies. J. Cell Biol. 137, 231-245.
68. Wong, C.W., Lee, A., Shientag, L., Yu, J., Dong, Y., Kao, G., Al-Mehdi, A.B., Bernhard, E.J., and Muschel, R.J. (2001). Apoptosis: an early event in metastatic inefficiency. Cancer Res. 61, 333-338.
69. Zhang, L., Yu, J., Park, B.H., Kinzler, K.W., and Vogelstein, B. (2000). Role of BAX in the apoptotic response to anti-cancer agents. Science 290, 989-992.